Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins

Details for Australian Patent Application No. 2003240823 (hide)

Owner Elan Pharmaceuticals, Inc.

Inventors Thorsett, Eugene D; Pleiss, Michael A; Semko, Christopher M; Stappenbeck, Frank; Xu, Ying-zi; Smith, Jenifer; Konradi, Andrei W; Stupi, Brian P

Agent Griffith Hack

Pub. Number AU-B-2003240823

PCT Number PCT/US03/16804

PCT Pub. Number WO2003/099809

Priority 60/383,020 24.05.02 US

Filing date 27 May 2003

Wipo publication date 12 December 2003

Acceptance publication date 6 November 2008

International Classifications

C07D 239/69 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 239/50 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/383,020 24.05.02 US

5 February 2004 Application Open to Public Inspection

  Published as AU-B-2003240823

6 November 2008 Application Accepted

  Published as AU-B-2003240823

5 February 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 16 Jan 2009. Address for service in Australia - Griffith Hack Level 3 509 St Kilda Road Melbourne VIC 3004

28 May 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 16 Jan 2009

4 June 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003240824-Transmucosal delivery of cannabinoids

2003240822-ANTIBODIES THAT SPECIFICALLY BIND TO NEUROKININ B